🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 657.57 -0.6% NASDAQ 100: 590.86 -0.7% Dow Jones: 459.32 -0.8%

PROCEPT BioRobotics Corporation

PRCT Healthcare
$26.04 $-0.13 (-0.50%)
Market Cap: $1.47 B
Gurus Holding
2
Popularity Rank
#3508
% of Shares Held
0.28%
Net Activity (Q4 2025)
+$2.96 M

Guru Ownership Trend

Guru Analysis for PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Corporation (PRCT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.18 M.

Top institutional holders include Renaissance Technologies and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $2.96 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies who opened a new position. Conversely, Cliff Asness reduced exposure by 35.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$3.7 M
Total Buy Value
New Buys 1
Additions 0
-$732,483.35
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
1

FAQs for PROCEPT BioRobotics Corporation (PRCT)

Major holders include Renaissance Technologies ($3.7 M), Cliff Asness ($1.35 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 160,524 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.96 M, with 1 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited PRCT. The total reported sell value was $732,483.35.

Yes, 1 managers opened new positions in PRCT, and 0 increased their existing holdings. The total reported buy value was $3.7 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% New Buy 117,466 $3.7 M Q4 2025
0.00% Reduce -35.1% 43,058 $1.35 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form